Cybin is a company which focuses on the production and marketing of medical cannabis. It was listed in the Alt-X of the JSE 25th June 2024 as a special purpose acquisition company (SPAC) and plans to acquire Cilo Cybin Pharmaceutical. Cilo Cybin is to make 10% of its 71m ordinary shares available to the market - which probably means it will be very thinly traded at least to begin with. The company's CEO is Gabriel Theron.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.